Prangenix Therapeutics Private Limited - Company Profile

It is a business services private limited company based in Varanasi, Uttar Pradesh, India, established in 2025.
2025 Varanasi, Uttar Pradesh, India Active
Last Updated:
Access Report
About Prangenix Therapeutics Private Limited

Prangenix Therapeutics Private Limited, a active private limited company, was established on 21 June 2025 in Varanasi, Uttar Pradesh, India. it holds CIN: U86100UP2025PTC226678. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹70.00 K .

Formerly known as Prangenix Therapeutics Private Limited. Its leadership includes Bharati Singh (Director), Deepmala Katiyar (Director), Rajeev Vikram (Director). It is based at N3/65-C, Ganeshdhamcolony, Newada, Sunderpur, Varanasi, Uttar Pradesh, 221005.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U86100UP2025PTC226678

  • Registration Number

    226678

  • Incorporation Date

    21 June 2025

  • Authorized Capital

    ₹1.50 M

  • Paid-Up Capital

    ₹70.00 K

  • ROC Code

    Roc Kanpur

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.50 M
  • Paid Up Capital ₹ 70.00 K
  • Company Age 8 Months 3 Days
Company report

Prangenix Therapeutics Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Prangenix Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Prangenix Therapeutics Private Limited?
Current Directors
Name Designation Appointment Date Status
Bharati Singh Director 21 Jun 2025 Current
Deepmala Katiyar Director 21 Jun 2025 Current
Rajeev Vikram Director 21 Jun 2025 Current
Sushil Kumar Aggarwal Director 21 Jun 2025 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Prangenix Therapeutics.
Prangenix Therapeutics revenue growth over time
Prangenix Therapeutics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Prangenix Therapeutics?

Unlock access to Prangenix Therapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Prangenix Therapeutics?

Unlock and access historical data on people associated with Prangenix Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Prangenix Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Prangenix Therapeutics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Prangenix Therapeutics
Recent Activity within the Organization
  • Director Appointment

    Progress on Bharati Singh was appointed as a Director was appointed as a Director on 21 Jun 2025 & has been associated with this company since 8 months 3 days . was documented.

  • Director Appointment

    The activity Deepmala Katiyar was appointed as a Director was appointed as a Director on 21 Jun 2025 & has been associated with this company since 8 months 3 days . was completed.

  • Director Appointment

    Rajeev Vikram was appointed as a Director was appointed as a Director on 21 Jun 2025 & has been associated with this company since 8 months 3 days . was recorded as a recent event.

  • Director Appointment

    The activity Sushil Kumar Aggarwal was appointed as a Director was appointed as a Director on 21 Jun 2025 & has been associated with this company since 8 months 3 days . was completed.

  • Company Incorporation

    The activity Prangenix Therapeutics Private Limited was registered on 21 Jun 2025 with Roc Kanpur & aged 8 months 3 days as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Prangenix Therapeutics Private Limited?

The CIN of Prangenix Therapeutics Private Limited is U86100UP2025PTC226678.

Where is Prangenix Therapeutics Private Limited headquartered?

Prangenix Therapeutics Private Limited is headquartered at N3/65-C, Ganeshdhamcolony, Newada, Sunderpur, Varanasi, Uttar Pradesh, 221005.

When was Prangenix Therapeutics Private Limited incorporated?

Prangenix Therapeutics Private Limited was incorporated on 21 June 2025.

Who are the current directors of Prangenix Therapeutics Private Limited?

The current directors of Prangenix Therapeutics Private Limited are

Is Prangenix Therapeutics Private Limited a listed company?

Prangenix Therapeutics Private Limited is unlisted.

What is the capital structure of Prangenix Therapeutics Private Limited?

The authorized capital of Prangenix Therapeutics Private Limited is ₹1.50 M, and the paid-up capital is ₹70.00 K .

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available